Live Breaking News & Updates on Upin q4 earnings

Stay informed with the latest breaking news from Upin q4 earnings on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Upin q4 earnings and stay connected to the pulse of your community

Lupin shares slide 4% amid profit booking post March quarter results

Read more about Lupin shares slide 4% amid profit booking post March quarter results on Business Standard. During the past six trading days, Lupin outperformed the market and surged 15 per cent as compared to a per cent rise in the S&P BSE Sensex till Wednesday

South-africa , India , Asia-pacific , Latin-america , Lupin-share-price , Arkets , 4 , Harma , Upin-q4-result , Upin-q4-earnings , Upin-quarterly-results

Lupin share falls 3% post Q4 earnings, here's what brokerages say


Lupin share falls 3% post Q4 earnings, here's what brokerages say
Share of Lupin fell up to 3.7% to Rs 1165.95 against previous close of Rs 1,210 on BSE
BusinessToday.In | May 14, 2021 | Updated 12:33 IST
Lupin share trades higher than 20 day, 50 day, 100 day and 200 day moving averages but lower than 5 day moving averages.
Lupin share lost over 3% today after the firm reported a 18.15% rise in Q4 net profit. Share of Lupin fell up to 3.7% to Rs 1165.95 against previous close of Rs 1,210 on BSE.
The share trades higher than 20 day, 50 day, 100 day and 200 day moving averages but lower than 5 day moving averages. The share has gained 36.25% in one year and risen 20.37% since the beginning of this year.

India , Bansi-desai , Karan-vora , Motilal-oswal , Institutional-research-analyst , Lupin-share , Upin-q4-net-profit , Hare-of-lupin , Se , Upin-q4-earnings , Upin-share-falls , இந்தியா

Lupin back in the black in FY20, reports Rs 1,216-crore profit

Pharma major Lupin reported a net profit of Rs 1,216 crore for the fiscal ended March 2021 against a loss of Rs 269 crore in the previous fiscal. However, total income fell 3.53% to Rs 15,299 crore in FY20-21 against Rs 15,858 crore in FY19-20.

Sun-pharma , Nilesh-gupta , Cipla , Managing-director , Lupin-q4-net-profit , Upin-q4-earnings , Upin , Upin-total-income , Upin-fy20-net-profit , சூரியன்-பார்மா , நிலேஷ்-குப்தா , சிப்லா